1.CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients.
Antonio DRAGO ; Barbara MONTI ; Diana DE RONCHI ; Alessandro SERRETTI
Psychiatry Investigation 2015;12(1):118-124
OBJECTIVE: A relevant part of the social and personal burden caused by Bipolar Disorder (BD) is related to depressive phases. Authors investigated the genetic impact of a set of variations located in CRY1, a gene involved in the control of the circadian rhythms, towards depressive episodes in a sample of bipolar patients from the STEP-BD sample. As a secondary analysis, CYR1 variations were analyzed as predictors of sleep disruption. METHODS: 654 bipolar patients were included in the analysis. Data were available genome-wide. The part of the genome coding for the CRY1 was imputed and pruned according to standards in the field. 7 SNPs were available for the analysis. A correction for multitesting was applied and we had sufficient power (0.80) to detect a small-medium effect size (0.22) between two allelic frequencies each one represented by at least 300 subjects. RESULTS: Intronic rs10861688 was associated with the number of depressive events corrected for the times patients were assessed during the period of observation. In particular, AA subjects (n=21) had 4.46+/-3.15 events, AG (n=141) had 3.08+/-3.17 and GG (n=342) 2.65+/-2.97 (p=0.0048, beta=-0.22). No other significant associations were reported. CONCLUSION: We bring further evidence that genes involved in the regulation of circadian rhythms may be relevant to depressive bipolar phases. Independent confirmation analyses are mandatory.
Bipolar Disorder
;
Circadian Rhythm
;
Clinical Coding
;
Genes, vif
;
Genome
;
Humans
;
Introns
;
Polymorphism, Single Nucleotide
;
Recurrence*
2.Megakaryoblasts in a newborn with Down syndrome.
Sabrina BUORO ; Michela SEGHEZZI ; Gianmaria BORLERI ; Barbara MANENTI
Blood Research 2018;53(2):102-102
No abstract available.
Down Syndrome*
;
Humans
;
Infant, Newborn*
;
Megakaryocyte Progenitor Cells*
3.The Immune System in Irritable Bowel Syndrome.
Giovanni BARBARA ; Cesare CREMON ; Giovanni CARINI ; Lara BELLACOSA ; Lisa ZECCHI ; Roberto DE GIORGIO ; Roberto CORINALDESI ; Vincenzo STANGHELLINI
Journal of Neurogastroenterology and Motility 2011;17(4):349-359
The potential relevance of systemic and gastrointestinal immune activation in the pathophysiology and symptom generation in the irritable bowel syndrome (IBS) is supported by a number of observations. Infectious gastroenteritis is the strongest risk factor for the development of IBS and increased rates of IBS-like symptoms have been detected in patients with inflammatory bowel disease in remission or in celiac disease patients on a gluten free diet. The number of T cells and mast cells in the small and large intestine of patients with IBS is increased in a large proportion of patients with IBS over healthy controls. Mediators released by immune cells and likely from other non-immune competent cells impact on the function of enteric and sensory afferent nerves as well as on epithelial tight junctions controlling mucosal barrier of recipient animals, isolated human gut tissues or cell culture systems. Antibodies against microbiota antigens (bacterial flagellin), and increased levels of cytokines have been detected systemically in the peripheral blood advocating the existence of abnormal host-microbial interactions and systemic immune responses. Nonetheless, there is wide overlap of data obtained in healthy controls; in addition, the subsets of patients showing immune activation have yet to be clearly identified. Gender, age, geographic differences, genetic predisposition, diet and differences in the intestinal microbiota likely play a role and further research has to be done to clarify their relevance as potential mechanisms in the described immune system dysregulation. Immune activation has stimulated interest for the potential identification of biomarkers useful for clinical and research purposes and the development of novel therapeutic approaches.
Abdominal Pain
;
Animals
;
Antibodies
;
Biomarkers
;
Celiac Disease
;
Cell Culture Techniques
;
Cytokines
;
Diet
;
Diet, Gluten-Free
;
Gastroenteritis
;
Genetic Predisposition to Disease
;
Humans
;
Immune System
;
Inflammatory Bowel Diseases
;
Intestine, Large
;
Irritable Bowel Syndrome
;
Mast Cells
;
Metagenome
;
Risk Factors
;
T-Lymphocytes
;
Tight Junctions
4.Transient Receptor Potential Vanilloid 1 Expression and Functionality in MCF-7 Cells: A Preliminary Investigation.
Cristina VERCELLI ; Raffaella BARBERO ; Barbara CUNIBERTI ; Silvia RACCA ; Giuliana ABBADESSA ; Francesca PICCIONE ; Giovanni RE
Journal of Breast Cancer 2014;17(4):332-338
PURPOSE: Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel belonging to the transient receptor potential family, and it is expressed in different neoplastic tissues. Its activation is associated with regulation of cancer growth and progression. The aim of this research was to study the expression and pharmacological characteristics of TRPV1 in cells derived from human breast cancer MCF-7 cells. METHODS: TRPV1 presence was assessed by binding studies and Western blotting. Receptor binding characteristics were evaluated through competition assays, while 3-(4,5-dimethylthiazol-2-yl)-2,5,-dipheyltetrazolium bromide reduction assays were performed to confirm an early hypothesis regarding the modulation of cancer cell proliferation. The functionality of TRPV1 was evaluated by measuring Ca2+ uptake in the presence of increasing concentrations of TRPV1 agonists and antagonists. RESULTS: Binding studies identified a single class of TRPV1 (Bmax 1,492+/-192 fmol/mg protein), and Western blot showed a signal at 100 kDa corresponding to the molecular weight of human TRPV1. Among the different tested agonists and antagonists, anandamide (Ki: 2.8x10(-11) M) and 5-iodoresiniferatoxin (5-I-RTX) (Ki: 5.6x10(-11) M) showed the highest degrees of affinity for TRPV1, respectively. All tested TRPV1 agonists and antagonists caused a significant (p<0.05) decrease in cell growth rate in MCF-7 cells. For agonists and antagonists, the efficacy of tested compounds displayed the following rank order: resiniferatoxin>anandamide>capsaicin and 5-I-RTX=capsazepine, respectively. CONCLUSION: These data indicate that both TRPV1 agonists and antagonists induce significant inhibition of MCF-7 cell growth. Even though the mechanisms involved in the antiproliferative effects of TRPV1 agonists and antagonists should be further investigated, it has been suggested that agonists cause desensitization of the receptor, leading to alteration in Ca2+-influx regulation. By contrast, antagonists cause a functional block of the receptor with consequent fatal dysregulation of cell homeostasis.
Blotting, Western
;
Breast Neoplasms
;
Cell Proliferation
;
Homeostasis
;
Humans
;
MCF-7 Cells*
;
Molecular Weight
5.Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
Maurizio BENUCCI ; Valentina GROSSI ; Mariangela MANFREDI ; Arianna DAMIANI ; Maria INFANTINO ; Paolo MOSCATO ; Luigi CINQUANTA ; Elisa GREMESE ; Barbara TOLUSSO ; Luca PETRICCA ; Anna Laura FEDELE ; Stefano ALIVERNINI ; Fabiola ATZENI ; Giovanni MINISOLA ; Roberto VERNA
Annals of Laboratory Medicine 2020;40(2):101-113
Biological drugs, such as proteins and immunogens, are increasingly used to treat various diseases, including tumors and autoimmune diseases, and biological molecules have almost completely replaced synthetic drugs in rheumatology. Although biological treatments such as anti-tumor necrosis factor (TNF) drugs seem to be quite safe, they cause some undesirable effects, such as the onset of infections due to weakening of the immune system. Given the biological nature of these drugs, they might be recognized as extraneous; this would induce an immune reaction that neutralizes their effectiveness or lead to more serious consequences. Laboratories play a pivotal role in appropriate therapeutic management. The aim of this review was to underline the production of anti-drug antibodies during treatment with biological drugs and highlight the role of laboratories in ensuring appropriate use of these drugs.
6.The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria
Marta BOTTERO ; Valentina BORZILLO ; Stefano PERGOLIZZI ; Barbara Alicja JERECZEK-FOSSA ; Edy IPPOLITO ; Giovanni Piero FREZZA ; Lucio FORTUNATO ; Renzo CORVÒ ; Giovanni Luigi PAPPAGALLO ; Stefano ARCANGELI ; Stefano M. MAGRINI ; Rolando M. D'ANGELILLO
Journal of Breast Cancer 2021;24(3):241-252
Salvage mastectomy is currently considered the standard of care for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and postoperative radiotherapy (RT). Alternative treatment options for these patients, such as a second BCS followed by repeated RT, have been suggested. The panel of the Italian Association of Radiotherapy and Clinical Oncology developed clinical recommendations for second BCS followed by re-irradiation over mastectomy alone for women with IBTR using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the evidence to decision framework. The following outcomes were identified by the panel: locoregional control, metastasis-free survival, overall survival, and cancer-specific survival; acute and late toxicity, specific late toxicity, second locoregional tumor, and death related to treatment.An Embase and PubMed literature search was performed by two independent authors. Five retrospective observational studies were eligible for inclusion in the present analysis.According to the reports in the literature and our analysis, the advantages of second quadrantectomy and re-irradiation (re-QUART) outweigh its side effects, with overall good rates of survival and adequate toxicity without increasing costs. Given the very low level of evidence, the panel stated that a second BCS plus re-irradiation can be considered as an alternative to salvage mastectomy for selected patients with IBTR.
7.The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria
Marta BOTTERO ; Valentina BORZILLO ; Stefano PERGOLIZZI ; Barbara Alicja JERECZEK-FOSSA ; Edy IPPOLITO ; Giovanni Piero FREZZA ; Lucio FORTUNATO ; Renzo CORVÒ ; Giovanni Luigi PAPPAGALLO ; Stefano ARCANGELI ; Stefano M. MAGRINI ; Rolando M. D'ANGELILLO
Journal of Breast Cancer 2021;24(3):241-252
Salvage mastectomy is currently considered the standard of care for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and postoperative radiotherapy (RT). Alternative treatment options for these patients, such as a second BCS followed by repeated RT, have been suggested. The panel of the Italian Association of Radiotherapy and Clinical Oncology developed clinical recommendations for second BCS followed by re-irradiation over mastectomy alone for women with IBTR using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the evidence to decision framework. The following outcomes were identified by the panel: locoregional control, metastasis-free survival, overall survival, and cancer-specific survival; acute and late toxicity, specific late toxicity, second locoregional tumor, and death related to treatment.An Embase and PubMed literature search was performed by two independent authors. Five retrospective observational studies were eligible for inclusion in the present analysis.According to the reports in the literature and our analysis, the advantages of second quadrantectomy and re-irradiation (re-QUART) outweigh its side effects, with overall good rates of survival and adequate toxicity without increasing costs. Given the very low level of evidence, the panel stated that a second BCS plus re-irradiation can be considered as an alternative to salvage mastectomy for selected patients with IBTR.
8. Beeswax: A minireview of its antimicrobial activity and its application in medicine
Filippo FRATINI ; Giovanni CILIA ; Barbara TURCHI ; Antonio FELICIOLI ; Filippo FRATINI ; Antonio FELICIOLI
Asian Pacific Journal of Tropical Medicine 2016;9(9):839-843
Beeswax is the substance that forms the structure of a honeycomb; the bees secrete wax to build the honeycombs where to store honey. Thanks to its rich hydrophobic protective properties, the beeswax is in fact present within cosmetics and body products. Also, beeswax is used in the food industry: as a film to wrap cheese for maturing or as a food additive (E901) to give shine to the products. Exactly as the honey which it contains, beeswax is also characterized by several therapeutic properties of great interest to us; it is thought to be particularly effective in healing bruises, inflammation and burns. Recently, the interest of researchers has moved even on antimicrobial properties of beeswax although there are still few studies in the literature focused only on the action of beeswax. The few studies showed an antimicrobic effectiveness of beeswax against overall Staphylococcus aureus, Salmonella enterica, Candida albicans and Aspergillus niger; these inhibitory effects are enhanced synergistically with other natural products such as honey or olive oil. This minireview aims to be a collection of major scientific works that have considered the antimicrobial activity of beeswax alone or in combination with other natural products in recent years.
9.Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic
Giovanni Delli CARPINI ; Paolo Giorgi ROSSI ; Luca GIANNELLA ; Jacopo Di GIUSEPPE ; Nicolò CLEMENTE ; Francesco SOPRACORDEVOLE ; Maggiorino BARBERO ; Giorgio BOGANI ; Rosa De VINCENZO ; Massimo ORIGONI ; Francesco CANTATORE ; Barbara GARDELLA ; Mattia DOMINONI ; Ermelinda MONTI ; Carlo Antonio LIVERANI ; Anna VISCARDI ; Alessio PAGAN ; Andrea AMADORI ; Chiara ALESSI ; Matteo ANDOLFATTO ; Paolo CATTANI ; Annalisa PIERALLI ; Guido STEVENAZZI ; Andrea CIAVATTINI
Journal of Gynecologic Oncology 2023;34(1):e7-
Objective:
To evaluate the impact of healthcare reorganization during the severe acute respiratory syndrome coronavirus 2 pandemic on Italian colposcopy clinic activities, focusing on cervical excision procedures, follow-ups for conservative management of low-grade lesions, and follow-ups post cervical excision.
Methods:
Retrospective study conducted in 14 Italian colposcopy clinics. The number and clinical characteristics of cervical excisions, follow-ups for conservative management of low-grade lesions, and follow-ups after cervical excision were compared between the period March 1, 2019 to February 29, 2020 (pre-pandemic) and March 1, 2020 to February 28, 2021 (pandemic) with a Poisson regression analysis.
Results:
In the pandemic period, the number of cervical excisions was reduced by 8.8% (95% confidence interval [CI]=−15.6% to −2%; p=0.011). Excisions were less frequently performed in the operating room (−35.1%; 95% CI=−47.6% to −22.6%; p<0.001), the number of patients from spontaneous screening was reduced by −14.0% (95% CI=−23.4% to −4.6%; p=0.003), and the CO2-laser technique was used less frequently (−30%; 95% CI=−45.1% to −15.0%; p<0.001). As compared to the pre-pandemic period, the number of follow-ups for conservative management of low-grade lesions was reduced by −26.7% (95% CI=−39.0% to −14.4%; p<0.001), and the follow-up appointments after cervical excision were reduced by −51.0% (95% CI=−58.1% to −43.9%; p<0.001).
Conclusion
The most significant impact of the healthcare reorganization during the coronavirus disease 2019 pandemic was on follow-ups after cervical excision. The resumption of disrupted activities should follow a risk-based prioritization, starting from women in follow-up after cervical excision. It is advisable that the trend of performing cervical excision as an outpatient procedure is maintained in the post-pandemic period.
10.An in vitro prototype of a porcine biomimetic testis-like cell culture system: a novel tool for the study of reassembled Sertoli and Leydig cells.
Iva ARATO ; Giovanni LUCA ; Francesca MANCUSO ; Catia BELLUCCI ; Cinzia LILLI ; Mario CALVITTI ; Barbara C HANSEN ; Domenico MILARDI ; Giuseppe GRANDE ; Riccardo CALAFIORE
Asian Journal of Andrology 2018;20(2):160-165
At present, there is no reliable in vitro assembled prepubertal testis-like biomimetic organ culture system designed to assess the functional effects of human gonadotropins on Sertoli and Leydig cells. Spermatogenesis is regulated by endocrine, paracrine, and juxtacrine factors (testicular cross-talk), mainly orchestrated by gonadotropins such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) that play a pivotal role by stimulating Leydig and Sertoli cells, respectively. The aim of our study was to set up an in vitro prepubertal porcine bioengineered construct as a new model for experimental studies on reassembled Sertoli and Leydig cells. We have evaluated Sertoli and Leydig cells obtained from 15- to 20-day-old neonatal pig testes in terms of purity and function. Subsequently, purified Sertoli and enriched Leydig cells were subjected to coincubation to obtain an in vitro prepubertal porcine testis-like culture system. We performed enzyme-linked immunosorbent assay (ELISA) for anti-Müllerian hormone (AMH), inhibin B, and testosterone secretion in the medium, and Real-Time PCR analysis of AMH, inhibin B, FSH-r, aromatase, LHr, and 3β-HSD mRNA expression levels. This in vitro testis-like system was highly responsive to the effects of human gonadotropins and testosterone. AMH mRNA expression and secretion declined, and inhibin-B increased, while FSH-receptor expression was downregulated upon FSH/LH exposure/treatment. Finally, the production of testosterone was increased selectively upon LH treatment. In summary, our proposed model could help to better determine the action of human gonadotropins on Sertoli and Leydig cells. The potential usefulness of the system for shedding light into male infertility-related issues is evident.
3-Hydroxysteroid Dehydrogenases/metabolism*
;
Animals
;
Animals, Newborn
;
Anti-Mullerian Hormone/metabolism*
;
Aromatase/metabolism*
;
Cell Culture Techniques
;
Enzyme-Linked Immunosorbent Assay
;
Follicle Stimulating Hormone/pharmacology*
;
Hormones/pharmacology*
;
In Vitro Techniques
;
Inhibins/metabolism*
;
Leydig Cells/metabolism*
;
Luteinizing Hormone/pharmacology*
;
Male
;
Models, Biological
;
Real-Time Polymerase Chain Reaction
;
Receptors, FSH/metabolism*
;
Receptors, LH/metabolism*
;
Sertoli Cells/metabolism*
;
Swine
;
Testis/metabolism*
;
Testosterone/metabolism*